Nicholas T. Gutsche

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma”.

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma

Molecules(2020)10.3390/molecules26010004

N/A

0DataRank · unranked

53 citations

Nicholas T. Gutsche, Anna King, Kwamena E. Baidoo, Olivia J. Kelada, Peter L. Choyke +2 more

ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.31.926972

N/A

0DataRank · unranked

2 citations

Nicholas T. Gutsche, Meghan M. Bell, Rose Berman, Kwamena E. Baidoo, Blake M. Warner +6 more

Towards the stable chelation of radium for biomedical applications with an 18-membered macrocyclic ligand

Chemical Science(2021)10.1039/d0sc06867e

N/A

0DataRank · unranked

95 citations

Nikki A. Thiele, Nicholas T. Gutsche, Alexandria Villmer, Hanwen Zhang, Joshua J. Woods +5 more

225Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors

Journal of Nuclear Medicine(2022)10.2967/jnumed.122.264707

N/A

0DataRank · unranked

44 citations

Nicholas T. Gutsche, Natarajan Raju, Stanley Fayn, Kwamena E. Baidoo, Meghan M. Bell +10 more

Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET

Journal of Nuclear Medicine(2023)10.2967/jnumed.122.265171

N/A

0DataRank · unranked

60 citations

Anna King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski +10 more